June 21, 2017 - Financial News Media

MBRX News – Moleculin Announces Significant Discovery with Potential to Treat Pancreatic Cancer

Metabolic Inhibitor Shows Greater Ability to Kill Pancreatic Cancer Cell Lines – HOUSTON, TX – (https://financialnewsmedia.com News Alert) – Moleculin Biotech, Inc., (NASDAQ: MBRX) (“Moleculin” or the “Company”), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on […]

Sign up to stay informed on all the latest Market News Information

FINANCIALNEWSMEDIA.COM (FNM) IS A THIRD PARTY PUBLISHER AND NEWS DISSEMINATION SOLUTIONS PROVIDER OF MULTIMEDIA PLATFORMS THAT ENABLE OFFICERS & DIRECTORS, CORPORATE COMMUNICATORS, PUBLIC RELATIONS AND INVESTOR RELATIONS OFFICERS TO LEVERAGE CONTENT TO ENGAGE WITH ALL THEIR KEY AUDIENCES. ANY IDEAS AND OPINIONS PRESENTED IN ANY FNM NEWS ALERTS, VIDEO CLIPS, PRESS RELEASES, RSS FEEDS OR SOCIAL NETWORK POSTS ARE FOR INFORMATIONAL PURPOSES ONLY, AND DO NOT REFLECT THE OPINIONS OF FNM OR ANY OF ITS AFFILIATES, SUBSIDIARIES OR PARTNERS. UNDER NO CIRCUMSTANCES SHOULD ANY CONTENT CONTAINED HEREIN BE INTERPRETED TO REPRESENT TRADING OR INVESTMENT ADVICE. ALL VIEWERS AGREE THAT UNDER NO CIRCUMSTANCES WILL FNM, ITS SUBSIDIARIES, PARTNERS, OFFICERS, EMPLOYEES, AFFILIATES, OR AGENTS BE HELD LIABLE FOR ANY LOSS OR DAMAGE CAUSED BY YOUR RELIANCE ON INFORMATION CONTAINED ON THIS OR ANY AFFILIATED WEBSITE.